[HTML][HTML] BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients
L Jin, E Chen, S Dong, Y Cai, X Zhang, Y Zhou… - Oncotarget, 2016 - ncbi.nlm.nih.gov
The role of telomerase reverse transcriptase (TERT) gene promoter mutations in the
aggressiveness of papillary thyroid cancer (PTC) remains to be further investigated. Here we …
aggressiveness of papillary thyroid cancer (PTC) remains to be further investigated. Here we …
BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence
Purpose To investigate the prognostic value of the BRAF V600E mutation and the recently
identified TERT promoter mutation chr5: 1,295,228 C> T (C228T), individually and in their …
identified TERT promoter mutation chr5: 1,295,228 C> T (C228T), individually and in their …
Co-existence of BRAFV600E and TERT promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node …
H Ren, Y Shen, D Hu, W He, J Zhou, Y Cao… - Cancer management …, 2018 - Taylor & Francis
Background Mutations of BRAF V600E and TERT promoters are associated with thyroid
cancer development. This study further investigated association of these mutations with …
cancer development. This study further investigated association of these mutations with …
BRAF V600E and TERT promoter mutations in papillary thyroid carcinoma in Chinese patients
J Sun, J Zhang, J Lu, J Gao, X Ren, L Teng, H Duan… - PLoS …, 2016 - journals.plos.org
Background The BRAF V600E and telomerase reverse transcriptase (TERT) promoter
mutations have been reported in papillary thyroid carcinoma (PTC). The aim of this …
mutations have been reported in papillary thyroid carcinoma (PTC). The aim of this …
[PDF][PDF] Coexistence of TERT promoter and BRAF mutations in papillary thyroid carcinoma: added value in patient prognosis
M Melo, AG da Rocha, J Vinagre… - J Clin …, 2015 - researchgate.net
TO THE EDITOR: We read with interest the study by Xing et al 1 recently published inJournal
of Clinical Oncology, together with the accompanying editorial. 2 In their large series of …
of Clinical Oncology, together with the accompanying editorial. 2 In their large series of …
Impact of BRAF V600E and TERT Promoter Mutations on Response to Therapy in Papillary Thyroid Cancer
T Trybek, A Walczyk, D Gąsior-Perczak, I Pałyga… - …, 2019 - academic.oup.com
In this study, we examined the relationship between coexisting BRAF V600E and TERT
promoter mutations in papillary thyroid cancer (PTC) and response to therapy. PTC cases …
promoter mutations in papillary thyroid cancer (PTC) and response to therapy. PTC cases …
Effects of Coexistent BRAFV600E and TERT Promoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis
S Moon, YS Song, YA Kim, JA Lim, SW Cho, JH Moon… - Thyroid, 2017 - liebertpub.com
Background: The presence of a telomerase reverse transcriptase (TERT) promoter mutation
has been suggested as a potential prognostic marker for thyroid cancer, and a synergistic …
has been suggested as a potential prognostic marker for thyroid cancer, and a synergistic …
The predictive value of coexisting BRAFV600E and TERT promoter mutations on poor outcomes and high tumour aggressiveness in papillary thyroid carcinoma: A …
B Chen, Y Shi, Y Xu, J Zhang - Clinical endocrinology, 2021 - Wiley Online Library
BRAFV600E mutation is highly prevalent in patients with papillary thyroid carcinoma (PTC),
and TERT promoter (TERTp) mutation is strongly associated with cancer‐related mortality …
and TERT promoter (TERTp) mutation is strongly associated with cancer‐related mortality …
TERT promoter and BRAF V600E mutations in papillary thyroid cancer: a single-institution experience in Korea
MJ Kim, JK Kim, GJ Kim, SW Kang, J Lee, JJ Jeong… - Cancers, 2022 - mdpi.com
Simple Summary TERT promoter mutation has recently emerged as a promising prognostic
biomarker for aggressive papillary thyroid cancer (PTC), along with BRAF B600E mutation …
biomarker for aggressive papillary thyroid cancer (PTC), along with BRAF B600E mutation …
Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma—a meta‐analysis
HG Vuong, AMA Altibi, UNP Duong… - Clinical …, 2017 - Wiley Online Library
Introduction The use of molecular markers, especially BRAF and TERT promoter mutations,
for risk stratification in papillary thyroid carcinoma (PTC) is subject to continuing debate. In …
for risk stratification in papillary thyroid carcinoma (PTC) is subject to continuing debate. In …
相关搜索
- thyroid carcinoma promoter mutations
- thyroid carcinoma braf v600e
- thyroid carcinoma meta analysis
- tert promoter braf mutations
- tumor aggressiveness promoter mutations
- thyroid cancer tert promoter
- patient prognosis braf mutations
- thyroid carcinoma tumor aggressiveness
- tert promoter patient prognosis
- thyroid carcinoma patient prognosis
- chinese patients braf v600e
- poor outcomes promoter mutations
- predictive value promoter mutations
- meta analysis promoter mutations
- thyroid carcinoma poor outcomes
- thyroid carcinoma predictive value